Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89301-89350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05154162
PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
PHASE3Recruiting
660 participants
Started: Mar 2, 2022 · Completed: Mar 31, 2028
1 condition2 sponsors6 locations
NCT05285007
Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain
NARecruiting
60 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05608694
MRI Screening in Men at High Risk of Developing Prostate Cancer
NARecruiting
250 participants
Started: Mar 2, 2022 · Completed: Mar 1, 2039
1 condition1 sponsor2 locations
NCT05435248
Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
PHASE1/PHASE2Recruiting
354 participants
Started: Mar 2, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05250648
Clinical Trial on HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
PHASE4Recruiting
216 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2029
2 conditions2 sponsors31 locations
NCT04838522
A Study of Prucalopride in Breastfeeding Women With Constipation
N/ARecruiting
12 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT05153226
GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG
PHASE3Active, not recruiting
640 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
6 conditions1 sponsor23 locations
NCT05068908
Brain Connectivity Patterns in Chronic Temporomandibular Joint Disorders
N/ARecruiting
95 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05228431
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
PHASE2Recruiting
121 participants
Started: Mar 2, 2022 · Completed: May 1, 2028
1 condition1 sponsor1 location
NCT05093764
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
NARecruiting
20 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04049591
Higher vs. Lower Dose Heparin for PCI
NARecruiting
16,000 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT07087080
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
NARecruiting
350 participants
Started: Mar 2, 2022 · Completed: Nov 1, 2027
2 conditions2 sponsors1 location
NCT05259930
Impact of Dietary Assessment and Intervention on Outcomes in Liver Cirrhosis Patients
NARecruiting
130 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2025
2 conditions2 sponsors1 location
NCT05236660
Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention
NAActive, not recruiting
126 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors5 locations
NCT04951817
68Ga-PSMA PET/CT for Ra223 Assessment
NARecruiting
52 participants
Started: Mar 2, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT04865679
Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
NAActive, not recruiting
15 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor2 locations
NCT05139381
Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab
N/AActive, not recruiting
148 participants
Started: Mar 2, 2022 · Completed: Mar 12, 2026
1 condition1 sponsor1 location
NCT05142267
Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms
NARecruiting
120 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT04742751
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
PHASE2Active, not recruiting
96 participants
Started: Mar 2, 2022 · Completed: Nov 30, 2026
2 conditions4 sponsors1 location
NCT06514079
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
NARecruiting
21 participants
Started: Mar 2, 2022 · Completed: Aug 20, 2024
3 conditions1 sponsor1 location
NCT05082259
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
PHASE1Recruiting
48 participants
Started: Mar 2, 2022 · Completed: Mar 16, 2026
3 conditions4 sponsors3 locations
NCT05207358
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
PHASE4Recruiting
30 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05069038
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
PHASE2Recruiting
46 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2031
1 condition1 sponsor1 location
NCT04973306
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
PHASE2/PHASE3Recruiting
176 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2027
2 conditions16 sponsors1 location
NCT05050864
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
NARecruiting
276 participants
Started: Mar 2, 2022 · Completed: Mar 15, 2027
3 conditions1 sponsor1 location
NCT05268562
Ketamine and Kidney Injury in Cardiac Surgery
PHASE4Active, not recruiting
200 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05217940
Screening Women With Prior HPV for Anal Neoplasia
NARecruiting
300 participants
Started: Mar 2, 2022 · Completed: Jan 31, 2027
3 conditions3 sponsors3 locations
NCT05388123
Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia
PHASE2Active, not recruiting
20 participants
Started: Mar 2, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05179733
The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
PHASE3Recruiting
280 participants
Started: Mar 2, 2022 · Completed: Dec 25, 2025
1 condition29 sponsors1 location
NCT05333679
Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
NAActive, not recruiting
200 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2025
1 condition4 sponsors1 location
NCT04430517
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
EARLY_PHASE1Recruiting
50 participants
Started: Mar 2, 2022 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT05092412
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
PHASE2Active, not recruiting
30 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2025
3 conditions2 sponsors3 locations
NCT05175248
Nutritional Intervention for Endometriosis
NARecruiting
120 participants
Started: Mar 2, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04962477
Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy
N/AActive, not recruiting
30 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05057715
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
PHASE1Active, not recruiting
13 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2038
2 conditions2 sponsors1 location
NCT04667078
REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
PHASE3Recruiting
368 participants
Started: Mar 2, 2022 · Completed: Jan 2, 2027
1 condition2 sponsors9 locations
NCT05090371
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
PHASE4Recruiting
150 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor43 locations
NCT04905017
Trisol System EFS Study
NARecruiting
15 participants
Started: Mar 2, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor4 locations
NCT05597410
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
N/ARecruiting
3,418 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2030
5 conditions1 sponsor1 location
NCT05823766
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
N/AActive, not recruiting
300 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors9 locations
NCT06626893
"Integrative Omics Approaches for Leukemia Target Identification and Matched Therapeutic Intervention"
NARecruiting
100 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2025
2 conditions1 sponsor8 locations
NCT05272696
Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC
PHASE2Recruiting
86 participants
Started: Mar 1, 2022 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05566054
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
PHASE2Recruiting
92 participants
Started: Mar 1, 2022 · Completed: Sep 30, 2025
2 conditions8 sponsors1 location
NCT05132439
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
PHASE3Recruiting
200 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2031
1 condition4 sponsors1 location
NCT05500599
Effects on Recovery of Children of Intravenous Formulation of Fentanyl Citrate and Midazolam Orally for Premedication
NAActive, not recruiting
60 participants
Started: Mar 1, 2022 · Completed: Aug 28, 2025
1 condition1 sponsor1 location
NCT05199259
Multi-analyte Blood Test Clinical Trial
N/ARecruiting
1,200 participants
Started: Mar 1, 2022 · Completed: Mar 31, 2025
4 conditions1 sponsor7 locations
NCT05148871
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
PHASE2/PHASE3Active, not recruiting
200 participants
Started: Mar 1, 2022 · Completed: Oct 6, 2024
1 condition3 sponsors1 location
NCT05301478
Patient Specific 3D Printed Diabetic Insoles to Reduce Plantar Pressure
NAActive, not recruiting
25 participants
Started: Mar 1, 2022 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT06405464
Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures
N/ARecruiting
600 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06111989
Fitness to Drive Among Stroke Patients
N/ARecruiting
100 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location